Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pharmaxis financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2023-12-06
Market Capitalization
$20.2 M
2023-12-06
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.1M | 5.7M | 7.0M | 22.6M | 9.8M | 13.0M | ||
| Gross profit | 50.5M | 12.4M | 12.7M | 23.6M | 15.8M | 19.2M | 5.8M | 11.4M |
| Gross profit margin, % | 828.2% | 218.6% | 180.2% | 104.3% | 161.3% | 148.1% | ||
| Operating expense total | 40.1M | 28.9M | 25.3M | 24.2M | 27.0M | 29.2M | 19.3M | 19.7M |
| Depreciation and amortization | 3.4M | 2.9M | 3.2M | 3.2M | 3.2M | 1.8M | 232.0K | 223.0K |
| EBITDA | 10.4M | (16.5M) | (12.6M) | (544.0K) | (11.2M) | (10.0M) | (13.5M) | (8.3M) |
| EBITDA margin, % | 170.3% | -291.3% | -179.2% | -2.4% | -114.7% | -77.3% | ||
| EBIT | 7.0M | (19.4M) | (15.8M) | (3.7M) | (14.4M) | (11.9M) | (13.7M) | (8.5M) |
| EBIT margin, % | 115.3% | -341.6% | -225.3% | -16.3% | -147.8% | -91.6% | ||
| Interest income | 598.0K | 909.0K | 364.0K | 50.0K | 156.0K | 117.0K | 89.0K | 570.0K |
| Interest expense | 563.0K | 238.0K | 369.0K | 223.0K | 386.0K | 30.0K | ||
| Pre tax profit | 6.4M | (20.1M) | (13.9M) | (3.0M) | (1.9M) | (11.4M) | (13.7M) | (7.9M) |
| Income tax expense | (8.0K) | |||||||
| Net Income | 6.4M | (20.1M) | (13.9M) | (3.0M) | (1.9M) | (11.4M) | (13.7M) | (7.9M) |